Basis: Current FMP quote-based enterprise value / matching reported total assets. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Assets ratio is 0.44x as of 2026-10-06T22:42:22.203Z.
Calculation as of: 2026-10-06T22:42:22.203Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c421eb3f9cbf80487861bd205397d7cf152d6c676755a2868786c2d5add3cf98
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/ASSETS RATIO
0.44x
SECTOR MEDIAN · HEALTHCARE
1.58x
median of 780 covered companies
CURRENT VS SECTOR MEDIAN
-72.06%
vs the sector median at left
Market Cap
$3.28M
EV/Assets Ratio
N/A
TTM Avg
439.01x
3Y Avg
762.41x
5Y Avg
506.78x
Market Cap
$3.21M
EV/Assets Ratio
N/A
TTM Avg
0.58x
3Y Avg
1.41x
5Y Avg
2.90x
Market Cap
$3.30M
EV/Assets Ratio
0.76x
TTM Avg
1.99x
3Y Avg
3.05x
5Y Avg
3.27x
Market Cap
$3.14M
EV/Assets Ratio
0.01x
TTM Avg
0.90x
3Y Avg
0.89x
5Y Avg
1.31x
Market Cap
$3.07M
EV/Assets Ratio
0.63x
TTM Avg
0.85x
3Y Avg
2.16x
5Y Avg
2.16x
Market Cap
$3.50M
EV/Assets Ratio
N/A
TTM Avg
3.17x
3Y Avg
19.39x
5Y Avg
65.90x
| NAME | MARKET CAP | EV/ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MBody AI Ltd. (MBAI) | $3.25M | 0.44x | N/A | N/A | N/A |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.28M | N/A | 439.01x | 762.41x | 506.78x |
| Aethlon Medical, Inc. (AEMD)vs › | $3.21M | N/A | 0.58x | 1.41x | 2.90x |
| Nexalin Technology, Inc. (NXL)vs › | $3.30M | 0.76x | 1.99x | 3.05x | 3.27x |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.14M | 0.01x | 0.90x | 0.89x | 1.31x |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.07M | 0.63x | 0.85x | 2.16x | 2.16x |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | N/A | 8.42x | 19.79x | 42.42x |
| Eocene Ltd. (EOCN)vs › | $3.50M | N/A | N/A | N/A | N/A |
| Moolec Science S.A. (MLEC)vs › | $3.50M | N/A | 3.17x | 19.39x | 65.90x |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.53M | 0.20x | 2.26x | 1.92x | 1.96x |
EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
